Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 43, 2008 - Issue 6
Submit an article Journal homepage
643
Views
215
CrossRef citations to date
0
Altmetric
Original Article

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

Franco Brunello Divisione di Gastro-Epatologia, Ospedale San Giovanni Battista di Torino, Turin, ItalyCorrespondence[email protected]
, MD,
Andrea Veltri Istituto di Diagnostica ed Interventistica Radiologica, Università di Torino, Turin, Italy
,
Patrizia Carucci Divisione di Gastro-Epatologia, Ospedale San Giovanni Battista di Torino, Turin, Italy
,
Eva Pagano Unità di Epidemiologia dei Tumori, Università di Torino e CPO Piemonte, Italy
,
Giovannino Ciccone Unità di Epidemiologia dei Tumori, Università di Torino e CPO Piemonte, Italy
,
Paolo Moretto Istituto di Diagnostica ed Interventistica Radiologica, Università di Torino, Turin, Italy
,
Paola Sacchetto Istituto di Diagnostica ed Interventistica Radiologica, Università di Torino, Turin, Italy
,
Giovanni Gandini Istituto di Diagnostica ed Interventistica Radiologica, Università di Torino, Turin, Italy
&
Mario Rizzetto Divisione di Gastro-Epatologia, Ospedale San Giovanni Battista di Torino, Turin, Italy
 show all
Pages 727-735 | Received 30 Oct 2007, Published online: 08 Jul 2009

Citations (215)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Yanzhao Zhou, Yi Yang, Bingyan Zhou, Zhengzheng Wang, Ruili Zhu, Xun Chen, Jingzhong Ouyang, Qingjun Li & Jinxue Zhou. (2021) Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. Journal of Hepatocellular Carcinoma 8, pages 625-644.
Read now
Yuanqiang Lin, Qiang Wen, Li Guo, Hui Wang, Guoqing Sui & Zhixia Sun. (2018) A network meta-analysis on the efficacy and prognosis of different interventional therapies for early-stage hepatocellular carcinoma. International Journal of Hyperthermia 35:1, pages 450-462.
Read now
Gui-Qi Zhu, Min Sun, Wei-Ting Liao, Wei-Hua Yu, Shao-Lai Zhou, Zheng-Jun Zhou, Ying-Hong Shi, Jia Fan, Jian Zhou, Li-Xin Qiu & Zhi Dai. (2018) Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 12:9, pages 935-945.
Read now
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh & Manas Behera. (2018) Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepatic Oncology 5:2.
Read now
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis & Dimitrios Tsetis. (2018) Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepatic Oncology 5:2.
Read now
Zheng Li, Kai Zhang, Shu-Mei Lin, Deng-Hai Mi, Nong Cao, Zhi-Zhen Wen & Zhong-Xin Li. (2017) Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. International Journal of Hyperthermia 33:3, pages 237-246.
Read now
David Li, Josephine Kang & David C Madoff. (2014) Locally ablative therapies for primary and metastatic liver cancer. Expert Review of Anticancer Therapy 14:8, pages 931-945.
Read now
Hiroki Nishikawa, Toru Kimura, Ryuichi Kita & Yukio Osaki. (2013) Radiofrequency ablation for hepatocellular carcinoma. International Journal of Hyperthermia 29:6, pages 558-568.
Read now
Erik N.K. Cressman & David A. Jahangir. (2013) Dual mode single agent thermochemical ablation by simultaneous release of heat energy and acid: Hydrolysis of electrophiles. International Journal of Hyperthermia 29:1, pages 71-78.
Read now
Christopher L Tinkle & Daphne Haas-Kogan. (2012) Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics: Targets and Therapy 6, pages 207-219.
Read now
Xiao-Yu Yin & Ming-De Lu. (2009) Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 3:2, pages 121-130.
Read now
Ronnie TP Poon & Nicholas Borys. (2009) Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opinion on Pharmacotherapy 10:2, pages 333-343.
Read now
Kristian Bjøro. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:6, pages 643-644.
Read now

Articles from other publishers (202)

Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta RiemerUlrike Ritterbusch, Elke Roeb, Jörn RüsselBarbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina TholenJörg Trojan, Ingo van ThielArndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle & Nisar Malek. (2024) S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 62:02, pages e213-e282.
Crossref
Bradley Roth, Sriram Rao, Kenneth Huynh & Nadine Abi-Jaoudeh. 2024. IR Playbook. IR Playbook 485 498 .
Laura Crocetti, See Khim Sim & Riccardo Lencioni. 2020. Interventional Oncology. Interventional Oncology 1 14 .
Ros Wade, Emily South, Sumayya Anwer, Sahar Sharif-Hurst, Melissa Harden, Helen Fulbright, Robert Hodgson, Sofia Dias, Mark Simmonds, Ian Rowe, Patricia Thornton & Alison Eastwood. (2023) Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis. Health Technology Assessment, pages 1-172.
Crossref
Emily South, Ros Wade, Sumayya Anwer, Sahar Sharif‐Hurst, Melissa Harden, Helen Fulbright, Sofia Dias, Mark Simmonds, Ian Rowe, Patricia Thornton, Tze Min Wah & Alison Eastwood. (2023) The effectiveness of ablative and non‐surgical therapies for early hepatocellular carcinoma: Systematic review and network meta‐analysis of randomised controlled trials. Cancer Medicine 12:22, pages 20759-20772.
Crossref
Ha Il Kim, Jihyun An, Seungbong Han & Ju Hyun Shim. (2023) Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis. Clinical and Molecular Hepatology 29:4, pages 1013-1028.
Crossref
Marco Petrus Adrianus Wilhelmus Claasen, Dimitri Sneiders, Yannick Sebastiaan Rakké, René Adam, Sherrie Bhoori, Umberto Cillo, Constantino Fondevila, Maria Reig, Gonzalo Sapisochin, Parissa Tabrizian & Christian Toso. (2023) European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma. Transplant International 36.
Crossref
Jeffrey S. Wicks, Benjamin S. Dale, Luis Ruffolo, Ludia J. Pack, Richard Dunne, Marie A. Laryea, Roberto Hernandez-Alejandro & Ashwani Kumar Sharma. (2023) Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation. Journal of Clinical Medicine 12:15, pages 5006.
Crossref
Jia-peng Wu, Jie Yu, J. Brian Fowlkes, Ping Liang & Christian Pállson Nolsøe. (2023) US-guided ablation of tumors – where is it used and how did we get there. Med-X 1:1.
Crossref
Leonardo G. Fonseca, Andre T.C. Chen, Irai S. de Oliveira, Aline L. Chagas, Jaime A.P. Kruger & Flair J. Carrilho. (2023) Brazilian Landscape of Hepatocellular Carcinoma. JCO Global Oncology:9.
Crossref
Hongye Wang, Zhaorong Wu, Dan Cui, Yaoping Shi & Bo Zhai. (2023) Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects. Liver Research 7:2, pages 108-115.
Crossref
. (2023) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 23:1, pages 1-120.
Crossref
Florica Gadalean, Florina Parv, Ligia Petrica, Ioan Sporea, Bogdan Timar, Cristina Gluhovschi, Flaviu Bob, Oana Milas, Anca Simulescu, Mihaela Patruica, Lazar Chisavu, Ciorcan Mircea, Adalbert Schiller & Mirela Danila. (2023) Rapid Decline of Estimated Glomerular Filtration Rate and its Effect on Mortality Risk of Patients with Hepatocellular Carcinoma. Hepatitis Monthly 23:1.
Crossref
Lukas Luerken, Michael Haimerl, Michael Doppler, Wibke Uller, Lukas Philipp Beyer, Christian Stroszczynski & Ingo Einspieler. (2023) Aktueller Stand zu perkutanen lokalablativen Verfahren beim hepatozellulären Karzinom. TumorDiagnostik & Therapie 44:01, pages 46-58.
Crossref
Ya-Wen Zou, Zhi-Gang Ren, Ying Sun, Zhen-Guo Liu, Xiao-Bo Hu, Hai-Yu Wang & Zu-Jiang Yu. (2023) The latest research progress on minimally invasive treatments for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 22:1, pages 54-63.
Crossref
Gabriel Lazzarotto-da-Silva, Tomaz J. M. Grezzana-Filho, Leandro A. Scaffaro, Mauricio Farenzena, Rafaela K. Silva, Alexandre de Araujo, Soraia Arruda, Flavia H. Feier, Lucas Prediger, Glória S. Lazzaretti, Mario R. Alvares-da-Silva, Aljamir D. Chedid, Cleber R. P. Kruel & Marcio F. Chedid. (2023) Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation. Langenbeck's Archives of Surgery 408:1.
Crossref
Mohamed Abdulwahab Mohamed Ali, William Scott Harmsen, Khairy Hammam Morsy, Ghada Moustapha Kamal Galal, Terry M. Therneau & Lewis Rowland Roberts. (2022) Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation. BMC Cancer 22:1.
Crossref
Hop S. Tran Cao, Junichi Shindoh & Jean‐Nicolas Vauthey. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 16 .
. (2022) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 28:4, pages 583-705.
Crossref
Lukas Luerken, Michael Haimerl, Michael Doppler, Wibke Uller, Lukas Philipp Beyer, Christian Stroszczynski & Ingo Einspieler. (2022) Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 194:10, pages 1075-1086.
Crossref
Myo Jin Tang, Guy D Eslick, John S Lubel, Ammar Majeed, Avik Majumdar, William Kemp & Stuart K Roberts. (2022) Outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma: A systematic review and meta-analysis . World Journal of Meta-Analysis 10:4, pages 220-237.
Crossref
Sheng-Lei Yan, Chia-Jung Hu, Li-Yun Tsai & Chen-Yuan Hsu. (2022) Postoperative Lifestyle of Patients with Liver Cancer: An Exploratory Study in a Single Center in Taiwan. International Journal of Environmental Research and Public Health 19:16, pages 9883.
Crossref
Ping Yang & Ningjie Li. (2022) Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm. Journal of International Medical Research 50:7, pages 030006052211112.
Crossref
Maryam Barsch, Robert Thimme & Bertram Bengsch. (2022) Neue Therapieoptionen beim HCC*. InFo Hämatologie + Onkologie 25:1-2, pages 16-18.
Crossref
. (2022) 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 23:12, pages 1126.
Crossref
Gagandeep Brar, Andrew Kesselman, Anuj Malhotra & Manish A. Shah. (2022) Redefining Intermediate-Stage HCC Treatment in the Era of Immune Therapies. JCO Oncology Practice 18:1, pages 35-41.
Crossref
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter & Malek Nisar. (2022) S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie 60:01, pages e56-e130.
Crossref
A. Guibal, I. Seiller, F. Khemissa, V. Aufranc, M.A. Rehim, I. Fryder, G. Farouil & P. Chevallier. (2021) Recommandations opérationnelles en radiologie interventionnelle : destruction tumorale percutanée des tumeurs hépatiques. Journal d'imagerie diagnostique et interventionnelle 4:4, pages 231-237.
Crossref
Al B. BensonMichael I. D’AngelicaDaniel E. AbbottDaniel A. AnayaRobert AndersChandrakanth AreMelinda BachiniMitesh BoradDaniel BrownAdam BurgoynePrabhleen ChahalDaniel T. ChangJordan CloydAnne M. CoveyEvan S. GlazerLipika GoyalWilliam G. HawkinsRenuka IyerRojymon JacobR. Kate KelleyRobin KimMatthew LevineManisha PaltaJames O. ParkSteven RamanSanjay ReddyVaibhav SahaiTracey SchefterGagandeep SinghStacey SteinJean-Nicolas VautheyAlan P. VenookAdam Yopp, Nicole R. McMillianCindy HochstetlerSusan D. Darlow. (2021) Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 19:5, pages 541-565.
Crossref
Josep M. Llovet, Thierry De Baere, Laura Kulik, Philipp K. Haber, Tim F. Greten, Tim Meyer & Riccardo Lencioni. (2021) Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 18:5, pages 293-313.
Crossref
Sivesh K. Kamarajah, James R. Bundred, Peter Littler, Helen Reeves, Derek M. Manas & Steven A. White. (2021) Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials. HPB 23:4, pages 495-505.
Crossref
Terrence CH Hui, Justin Kwan & Uei Pua. (2021) Advanced Techniques in the Percutaneous Ablation of Liver Tumours. Diagnostics 11:4, pages 585.
Crossref
Eric MastrolonardoJemianne Bautista JiaBryce EngJennifer SakiokaCuong LamDennis Der. (2020) Comparison of percutaneous ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma. American Journal of Interventional Radiology 4, pages 16.
Crossref
Anjana A. Pillai, Meera Ramanathan & Laura Kulik. (2020) Locoregional Therapies for Hepatocellular Carcinoma. Clinics in Liver Disease 24:4, pages 681-700.
Crossref
Yun-Jau Chang, Li-Ju Chen, Yao-Jen Chang & Po-Da Chen. (2020) Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma. European Journal of Surgical Oncology 46:9, pages 1703-1710.
Crossref
Katherine S. Cools, Andrew M. Moon, Lauren M. B. Burke, Katrina A. McGinty, Paula D. Strassle & David A. Gerber. (2019) Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma. Liver Transplantation 26:2, pages 203-214.
Crossref
Nicolas Voizard, Milena Cerny, Anis Assad, Jean-Sébastien Billiard, Damien Olivié, Pierre Perreault, Ania Kielar, Richard K. G. Do, Takeshi Yokoo, Claude B. Sirlin & An Tang. (2019) Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights into Imaging 10:1.
Crossref
Janine Rennert, Isabel Wiesinger, Lukas Philipp Beyer, Andreas Schicho, Christian Stroszczynski, Philipp Wiggermann & Ernst Michael Jung. (2019) Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies. Clinical Hemorheology and Microcirculation 73:1, pages 73-83.
Crossref
Marco Calandri, Valeria Ruggeri, Patrizia Carucci, Stefano Mirabella, Andrea Veltri, Paolo Fonio & Carlo Gazzera. (2019) Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter. La radiologia medica 124:10, pages 1043-1048.
Crossref
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski & Devalingam Mahalingam. (2019) Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC). Cancers 11:8, pages 1085.
Crossref
Kevin Ka Wan Chu & Kenneth Siu Ho Chok. (2019) Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?. World Journal of Gastroenterology 25:27, pages 3563-3571.
Crossref
KLCA Korean Liver Cancer Association & NCC National Cancer Center. (2019) 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 13:3, pages 227-299.
Crossref
Marco Calandri, Giovanni Mauri, Steven Yevich, Carlo Gazzera, Domenico Basile, Marco Gatti, Andrea Veltri & Paolo Fonio. (2019) Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature. CardioVascular and Interventional Radiology 42:5, pages 639-647.
Crossref
Alexa Childs & Tim Meyer. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 703 714 .
Jinhai Huo, Thomas A. Aloia, Ying Xu, Tong Han Chung, Tommy Sheu & Ya-Chen Tina Shih. (2019) Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value in Health 22:3, pages 284-292.
Crossref
Yi-Quan Jiang, Zi-Xian Wang, Yi-Nan Deng, Yang Yang, Guo-Ying Wang & Gui-Hua Chen. (2019) Efficacy of Hepatic Resection vs. Radiofrequency Ablation for Patients With Very-Early-Stage or Early-Stage Hepatocellular Carcinoma: A Population-Based Study With Stratification by Age and Tumor Size. Frontiers in Oncology 9.
Crossref
. (2019) 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 20:7, pages 1042.
Crossref
SHUICHIRO SHIINA, RYO KANAZAWA, YASUYUKI KOMIYAMA, SHIGETO ISHII, MASASHI TAKAWA, HIROAKI NAGAMATSU & HITOSHI MARUYAMA. (2019) Ablation for Liver Tumors. Juntendo Medical Journal 65:5, pages 433-443.
Crossref
Giampiero Francica, Michele Altiero, Ettore Laccetti, Filomena Pezzullo, Michela Tanga, Giuseppe Avitabile, Mathew Elameer & Mariano Scaglione. (2019) Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system. The British Journal of Radiology 92:1093.
Crossref
Sahin Lacin, Asif Rashid, Yun Shin Chun, Bruno Calazans Odisio, Eugene J. Koay, Reham Abdel-Wahab & Ahmed O. Kaseb. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology 207 234 .
Guangcong Zhang, Xiangnan Yu, Peng Liu, Xiaoxi Huang & Xuemei Jiang. (2018) Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis. Digestive Diseases and Sciences 63:12, pages 3207-3219.
Crossref
Guo Tian, Shigui Yang, Jinqiu Yuan, Diane Threapleton, Qiyu Zhao, Fen Chen, Hongcui Cao, Tian’an Jiang & Lanjuan Li. (2018) Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis. BMJ Open 8:10, pages e021269.
Crossref
Shuichiro Shiina, Koki Sato, Ryosuke Tateishi, Motonori Shimizu, Hideko Ohama, Takeshi Hatanaka, Masashi Takawa, Hiroaki Nagamatsu & Yasuharu Imai. (2018) Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. Canadian Journal of Gastroenterology and Hepatology 2018, pages 1-8.
Crossref
D. Putzer, P. Schullian, E. Braunwarth, M. Fodor, F. Primavesi, B. Cardini, T. Resch, R. Oberhuber, M. Maglione, C. Margreiter, S. Schneeberger, S. Stättner, D. Öfner-Velano, W. Jaschke & R. J. Bale. (2018) Integrating interventional oncology in the treatment of liver tumors. European Surgery 50:3, pages 117-124.
Crossref
Lung-Yi MakVania Cruz-RamónPaulina Chinchilla-LópezHarrys A. TorresNoelle K. LoConteJohn P. RiceLewis E. FoxhallErich M. SturgisJanette K. MerrillHoward H. BaileyNahum Méndez-SánchezMan-Fung YuenJessica P. Hwang. (2018) Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book:38, pages 262-279.
Crossref
Jean-Charles Nault, Olivier Sutter, Pierre Nahon, Nathalie Ganne-Carrié & Olivier Séror. (2018) Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. Journal of Hepatology 68:4, pages 783-797.
Crossref
Li, MD Meng, Li, MD Zhiyan, Gao, MD Yuejuan, Tian, MD Jiangke, Chen, MD Min & Dong, MD Jinghui. (2018) Safety and Efficacy of Percutaneous Radiofrequency Ablation Combined with Percutaneous Ethanol Injection for Hepatocellular Carcinoma in High-risk Locations. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2:1, pages 1.
Crossref
Jimmy Ton, Edward Kuoy & Nadine Abi-Jaoudeh. 2018. IR Playbook. IR Playbook 397 403 .
Joydeep Chakraborty, Eric Hilgenfeldt & Roniel Cabrera. 2018. Precision Molecular Pathology of Liver Cancer. Precision Molecular Pathology of Liver Cancer 175 194 .
Wen Luo, Yunfei Zhang, Guangbin He, Ming Yu, Minjuan Zheng, Liwen Liu & Xiaodong Zhou. (2017) Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World Journal of Surgical Oncology 15:1.
Crossref
Hao-Wen Sim, Jennifer Knox & Laura A. Dawson. (2017) An Update on Randomized Clinical Trials in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 26:4, pages 647-666.
Crossref
Anne M. CoveyShahid M. Hussain. (2017) Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. American Journal of Roentgenology 209:1, pages 67-76.
Crossref
Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana Alcantara Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei-Jer Chen, Cosmas Rinaldi A. Lesmana, Laurentius A. Lesmana, Rino A. Gani, Shuntaro Obi, A. Kadir Dokmeci & Shiv Kumar Sarin. (2017) Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology International 11:4, pages 317-370.
Crossref
Kun Li, Hai-Tao Wang, Yu-Kun He & Tao Guo. (2017) New idea for treatment strategies for Barcelona Clinic Liver Cancer stages based on a network meta-analysis. Medicine 96:20, pages e6950.
Crossref
Avik Majumdar, Davide Roccarina, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis & Kurinchi Selvan Gurusamy. (2017) Management of people with early- or very early-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie & Zhimin Suo. (2016) Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 8:9, pages 15101-15113.
Crossref
Junichi Shindoh, Kristoffer W. Brudvik & Jean‐Nicolas Vauthey. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 14 .
Satoshi Katagiri, Shingo Yamashita, Godai Yoneda, Yuuichi Igarashi, Akiko Oomori, Takaaki Kato, Akira Nemoto, Yoshihito Kotera, Shun-ichi Ariizumi, Hirohito Egawa, Tatsuo Araida, Katsutoshi Tokushige & Masakazu Yamamoto. (2017) Verification of therapy for hepatocellular carcinoma of less than 3 cm -Hepatectomy versus percutaneous radio-frequency ablation therapy-. Journal of Microwave Surgery 35:2, pages 1-6.
Crossref
Matthew Cwinn, Gordon Walsh, Sheikh Hasibur Rahman & Michele Molinari. (2017) The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes. Canadian Journal of Gastroenterology and Hepatology 2017, pages 1-8.
Crossref
Vitor Moutinho, Michael I. D'Angelica & T. Peter Kingham. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 1459 1469.e2 .
Tian-an Jiang, Zhuang Deng, Guo Tian, Qi-yu Zhao & Wei-lin Wang. (2016) Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Scientific Reports 6:1.
Crossref
Mostafa M. Shakweer, Abdelshafy A. Awad Allah & Abdel-Aziz K. Aun. (2016) Common interventional techniques (single versus combined) in management of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 47:4, pages 1407-1413.
Crossref
Young‐Seok Seo, Mi‐Sook Kim, Hyung‐Jun Yoo, Won Il Jang, Eun Kyung Paik, Chul Ju Han & Byung‐Hee Lee. (2016) Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis. Cancer Medicine 5:11, pages 3094-3101.
Crossref
Danielle K. DePeralta & Kenneth K. Tanabe. 2016. Laparoscopic Liver, Pancreas, and Biliary Surgery. Laparoscopic Liver, Pancreas, and Biliary Surgery 257 272 .
Alessia Guarneri, Pierfrancesco Franco, Elisabetta Trino, Daniela Campion, Riccardo Faletti, Stefano Mirabella, Silvia Gaia, Riccardo Ragona, Margherita Diotallevi, Giorgio Saracco, Mauro Salizzoni, Umberto Ricardi & Patrizia Carucci. (2016) Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm. Medical Oncology 33:10.
Crossref
Jin Woo Choi, Jeong Min Lee, Dong Ho Lee, Jeong-Hee Yoon, Kyung-Suk Suh, Jung-Hwan Yoon, Yoon Jun Kim, Jeong-Hoon Lee, Su Jong Yu & Joon Koo Han. (2016) Switching Monopolar Radiofrequency Ablation Using a Separable Cluster Electrode in Patients with Hepatocellular Carcinoma: A Prospective Study. PLOS ONE 11:8, pages e0161980.
Crossref
Laura Crocetti, Maria Clotilde Della Pina, Dania Cioni & Riccardo Lencioni. 2016. Interventional Oncology. Interventional Oncology 91 99 .
Olivier Seror, Gisèle N’Kontchou, Jean-Charles Nault, Yacine Rabahi, Pierre Nahon, Nathalie Ganne-Carrié, Véronique Grando, Nora Zentar, Michel Beaugrand, Jean-Claude Trinchet, Abou Diallo & Nicolas Sellier. (2016) Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment—Long-term Results. Radiology 280:2, pages 611-621.
Crossref
Su Jong Yu, Jung-Hwan Yoon, Jeong Min Lee, Jae Young Lee, Se Hyung Kim, Young Youn Cho, Jeong-Ju Yoo, Minjong Lee, Dong Hyeon Lee, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim & Chung Yong Kim. (2016) Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm. Medicine 95:35, pages e4551.
Crossref
Miral Sadaria Grandhi, Amy K. Kim, Sean M. Ronnekleiv-Kelly, Ihab R. Kamel, Mounes A. Ghasebeh & Timothy M. Pawlik. (2016) Hepatocellular carcinoma: From diagnosis to treatment. Surgical Oncology 25:2, pages 74-85.
Crossref
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay & Ahmet Coker. (2016) Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 15:3, pages 234-256.
Crossref
Tian Lan, Lei Chang, Rahmathullah MN, Long Wu & Yu-Feng Yuan. (2016) Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma. Medicine 95:15, pages e3185.
Crossref
Antonio Facciorusso, Gaetano Serviddio & Nicola Muscatiello. (2016) Local ablative treatments for hepatocellular carcinoma: An updated review. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:4, pages 477.
Crossref
Yaoping Shi & Bo Zhai. (2016) A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma. Gastrointestinal Tumors 3:2, pages 90-102.
Crossref
Antonio Facciorusso & Michele Barone. 2016. Hepatocellular Carcinoma. Hepatocellular Carcinoma 453 466 .
Divya Sharma, Robert A. Schwartz & William Abramovits. 2016. Dermatological Cryosurgery and Cryotherapy. Dermatological Cryosurgery and Cryotherapy 277 281 .
Biao Yang, Rui-yu Zan, Shi-yu Wang, Xiang-lian Li, Mao-ling Wei, Wen-hao Guo, Xin You, Jing Li & Zheng-yin Liao. (2015) Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World Journal of Surgical Oncology 13:1.
Crossref
Amit Singal & Jorge A. Marrero. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 2146 2165 .
Claire Faltermeier, Ronald Busuttil & Ali Zarrinpar. (2015) A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases 3:4, pages 221-252.
Crossref
Shane A. Wells, J. Louis Hinshaw, Meghan G. Lubner, Timothy J. Ziemlewicz, Christopher L. Brace & Fred T. LeeJr.Jr.. (2015) Liver Ablation. Radiologic Clinics of North America 53:5, pages 933-971.
Crossref
Matteo Ruggeri, Andrea Manca, Silvia Coretti, Paola Codella, Valentina Iacopino, Federica Romano, Daniele Mascia, Valentina Orlando & Americo Cicchetti. (2015) Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review. Value in Health 18:5, pages 709-720.
Crossref
Benyam D. Addissie & Lewis R. Roberts. (2015) Classification and Staging of Hepatocellular Carcinoma. Clinics in Liver Disease 19:2, pages 277-294.
Crossref
Gian Ludovico Rapaccini. (2015) Percutaneous ablative treatments of hepatocellular carcinoma. Hepatology 61:5, pages 1465-1466.
Crossref
Chunping Wang, Huaming Wang, Wuwei Yang, Kaiwen Hu, Hui Xie, Ke‐Qin Hu, Wenlin Bai, Zheng Dong, Yinying Lu, Zhen Zeng, Min Lou, Hong Wang, Xudong Gao, Xiujuan Chang, Linjing An, Jianhui Qu, Jin Li & Yongping Yang. (2015) Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 61:5, pages 1579-1590.
Crossref
Eli Sapir, Eman ElAlfy, Paula Novelli & Mary Feng. (2015) Liver cancer turf wars. Applied Radiation Oncology, pages 8-13.
Crossref
Giovan Giuseppe Di Costanzo, Raffaella Tortora, Giuseppe D'Adamo, Massimo De Luca, Filippo Lampasi, Luigi Addario, Alfonso Galeota Lanza, Francesco Paolo Picciotto, Maria Teresa Tartaglione, Gabriella Cordone, Michele Imparato, Silvana Mattera & Claudio Maurizio Pacella. (2015) Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial . Journal of Gastroenterology and Hepatology 30:3, pages 559-565.
Crossref
Mohamed A. Chinnaratha, Dharshan Sathananthan, Puraskar Pateria, Edmund Tse, Gerry MacQuillan, Leigh Mosel, Ramon Pathi, Dan Madigan & Alan J. Wigg. (2015) High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice. European Journal of Gastroenterology & Hepatology 27:3, pages 349-354.
Crossref
David J. Breen & Riccardo Lencioni. (2015) Image-guided ablation of primary liver and renal tumours. Nature Reviews Clinical Oncology 12:3, pages 175-186.
Crossref
Suguru Yamashita, Taku Aoki, Yosuke Inoue, Junichi Kaneko, Yoshihiro Sakamoto, Yasuhiko Sugawara, Kiyoshi Hasegawa & Norihiro Kokudo. (2015) Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery 157:3, pages 463-472.
Crossref
Orlando Catalano, Francesco Izzo, Paolo Vallone, Fabio Sandomenico, Vittorio Albino, Antonio Nunziata, Roberta Fusco & Antonella Petrillo. (2015) Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience. Acta Radiologica 56:2, pages 133-142.
Crossref
Sebastian Weis, Annegret Franke, Thomas Berg, Joachim Mössner, Wolfgang E. Fleig & Konrad Schoppmeyer. (2015) Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2019:2.
Crossref
Abhijeet Waghray. (2015) Hepatocellular carcinoma: From diagnosis to treatment. World Journal of Hepatology 7:8, pages 1020.
Crossref
Magdy Hamed Attwa. (2015) Guide for diagnosis and treatment of hepatocellular carcinoma. World Journal of Hepatology 7:12, pages 1632.
Crossref
Kevin Ka Wan Chu. (2015) Update in management of hepatocellular carcinoma in Eastern population. World Journal of Hepatology 7:11, pages 1562.
Crossref
Francesco Bellissimo. (2015) Diagnostic and therapeutic management of hepatocellular carcinoma. World Journal of Gastroenterology 21:42, pages 12003.
Crossref
Alexander Schlachterman. (2015) Current and future treatments for hepatocellular carcinoma. World Journal of Gastroenterology 21:28, pages 8478.
Crossref
. (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 16:3, pages 465.
Crossref
Paul D. Hansen, Maria A. Cassera & Ronald F. Wolf. (2015) Ablative Technologies for Hepatocellular, Cholangiocarcinoma, and Metastatic Colorectal Cancer of the Liver. Surgical Oncology Clinics of North America 24:1, pages 97-119.
Crossref
Rong-Hua Xu, Wei Gao, Chao Wang, De-Kai Guo, Lin Tang, Hui Zhang & Cong-Jun Wang. (2014) RETRACTED ARTICLE: Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis. European Journal of Medical Research 19:1.
Crossref
Mauricio F. Silva, Flair J. Carrilho, Denise C. Paranaguá-Vezozzo, Luciana T. Campos, Lucas S. Nacif, Marcio A. Diniz, Alberto Q. Farias, Venancio A.F. Alves, Luis A.C. D’Alburquerque & Suzane K. Ono. (2014) m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma. Annals of Hepatology 13:6, pages 796-802.
Crossref
Bruno C. Odisio & Michael J. Wallace. (2014) Image-Guided Interventions in Oncology. Surgical Oncology Clinics of North America 23:4, pages 937-955.
Crossref
Ragesh B. Thandassery, Usha Goenka & Mahesh K. Goenka. (2014) Role of Local Ablative Therapy for Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 4, pages S104-S111.
Crossref
C.M. Sommer, U. Stampfl, H.U. Kauczor & P.L. Pereira. (2014) Nationale S3-Leitlinie hepatozelluläres KarzinomNational S3 guidelines on hepatocellular carcinoma. Der Radiologe 54:7, pages 642-653.
Crossref
Dirk Graf, Daniel Vallböhmer, Wolfram Trudo Knoefel, Patric Kröpil, Gerald Antoch, Abdurrahaman Sagir & Dieter Häussinger. (2014) Multimodal treatment of hepatocellular carcinoma. European Journal of Internal Medicine 25:5, pages 430-437.
Crossref
Andrew J. Page, David C. Cosgrove, Benjamin Philosophe & Timothy M. Pawlik. (2014) Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 23:2, pages 289-311.
Crossref
Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Takashi Kobayashi, Shogo Iwabutchi, Kotaro Matsunaga, Tomikazu Mizuno, Kae Yashiro, Shuichi Nisimura & Etsuo Kunieda. (2014) Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 29:2, pages 372-379.
Crossref
J.G. Baust, A.A. Gage, T.E. Bjerklund Johansen & J.M. Baust. (2014) Mechanisms of cryoablation: Clinical consequences on malignant tumors. Cryobiology 68:1, pages 1-11.
Crossref
Parissa Tabrizian. (2014) Current management of hepatocellular carcinoma. World Journal of Gastroenterology 20:30, pages 10223.
Crossref
Wei Dong. (2014) Clinical outcome of small hepatocellular carcinoma after different treatments: A meta-analysis. World Journal of Gastroenterology 20:29, pages 10174.
Crossref
Reena Salgia & Amit G. Singal. (2014) Hepatocellular Carcinoma and Other Liver Lesions. Medical Clinics of North America 98:1, pages 103-118.
Crossref
Gabriella Pittau, Michele Tedeschi & Denis Castaing. 2014. Abdominal Ultrasound for Surgeons. Abdominal Ultrasound for Surgeons 201 218 .
Sebastian Weis, Annegret Franke, Joachim Mössner, Janus C Jakobsen & Konrad Schoppmeyer. (2013) Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Zhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, Yu-Yun Shao, Yi-Chun Yeh, Raymond Nien-Chen Kuo, Chih-Hung Hsu, James Chih-Hsin Yang, Ann-Lii Cheng & Mei-Shu Lai. (2013) Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size. PLoS ONE 8:11, pages e80276.
Crossref
Ryan T. Groeschl, T. Clark Gamblin & Kiran K. Turaga. (2013) Ablation for Hepatocellular Carcinoma: Validating the 3-cm Breakpoint. Annals of Surgical Oncology 20:11, pages 3591-3595.
Crossref
Jeffrey S. Pollak. (2013) Consider the Perspectives. Journal of Clinical Gastroenterology 47:Supplement 1, pages S43-S46.
Crossref
F. Imani, P. Abolmaesumi, M. Z. Wu, A. Lasso, E. C. Burdette, G. Ghoshal, T. Heffter, E. Williams, P. Neubauer, G. Fichtinger & P. Mousavi. (2013) Ultrasound-Guided Characterization of Interstitial Ablated Tissue Using RF Time Series: Feasibility Study. IEEE Transactions on Biomedical Engineering 60:6, pages 1608-1618.
Crossref
Massimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, Peter R. Galle, Jessica Zucman-Rossi, Rafael Bañares, Daniel Seehofer, Peter Neuhaus & Philip Johnson. (2013) Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 25:6, pages 639-651.
Crossref
Ai Shen, Hua Zhang, Chengyong Tang, Yong Chen, Yefei Wang, Chao Zhang & Zhongjun Wu. (2013) A systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. Journal of Gastroenterology and Hepatology 28:5, pages 793-800.
Crossref
Kunjali T. Padhya, Jorge A. Marrero & Amit G. Singal. (2013) Recent advances in the treatment of hepatocellular carcinoma. Current Opinion in Gastroenterology 29:3, pages 285-292.
Crossref
Giampiero Francica, Antonio Saviano, Ilario De Sio, Nicoletta De Matthaeis, Franco Brunello, Alessandro Cantamessa, Antonio Giorgio, Umberto Scognamiglio, Fabio Fornari, Francesco Giangregorio, Fabio Piscaglia, Silvia Gualandi, Eugenio Caturelli, Paola Roselli, Gian Ludovico Rapaccini & Maurizio Pompili. (2013) Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients. Digestive and Liver Disease 45:4, pages 336-341.
Crossref
Ji-Wen Cheng & Yi Lv. (2013) New progress of non-surgical treatments for hepatocellular carcinoma. Medical Oncology 30:1.
Crossref
N. Wong, A. Haydon, W. Kemp, P. Wijeratne & S. Roberts. (2013) Improved survival trend of patients with hepatocellular carcinoma at an A ustralian tertiary hospital between 1995–2009 . Internal Medicine Journal 43:2, pages 197-203.
Crossref
Andrea Mancuso. (2013) Management of hepatocellular carcinoma: Enlightening the gray zones. World Journal of Hepatology 5:6, pages 302.
Crossref
Tamer Elbaz, Mohamed El Kassas & Gamal Esmat. (2013) Management of Hepatocellular Carcinoma: Updated Review. Journal of Cancer Therapy 04:02, pages 536-545.
Crossref
Eric C.H. Lai & Chung Ngai Tang. (2013) Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria – A comparative study. International Journal of Surgery 11:1, pages 77-80.
Crossref
Stephan Clasen, Philippe L. Pereira, Andreas Lubienski, Arnd-Oliver Schäfer, Andreas H. Mahnken, Thomas Helmberger, Martin G. Mack, Katrin Eichler, Thomas J. Vogl, Christian Rosenberg, Suzanne C. Schiffman, Robert C. G. Martin, Thierry de Baère, Philipp Bruners, Markus Düx, Konrad Mohnike, Jens Ricke, Philip Ditter, Kai E. Wilhelm, Holger Strunk, Alexander Beck, Susanne Hengst, Joseph P. Erinjeri & Thomas Gast. 2013. CT- and MR-Guided Interventions in Radiology. CT- and MR-Guided Interventions in Radiology 205 362 .
Riccardo Lencioni & Laura Crocetti. 2013. Multidisciplinary Treatment of Hepatocellular Carcinoma. Multidisciplinary Treatment of Hepatocellular Carcinoma 181 194 .
Riccardo Lencioni & Laura Crocetti. 2013. Image-Guided Cancer Therapy. Image-Guided Cancer Therapy 339 343 .
Ming Kuang & Ming-De Lu. 2013. Image-Guided Cancer Therapy. Image-Guided Cancer Therapy 317 326 .
Laura Crocetti & Riccardo Lencioni. 2013. Image-Guided Cancer Therapy. Image-Guided Cancer Therapy 293 301 .
Ronald S. Winokur & Daniel B. Brown. 2013. Interventional Radiology Techniques in Ablation. Interventional Radiology Techniques in Ablation 115 137 .
Mercedes Iñarrairaegui & Bruno Sangro. 2014. Liver Radioembolization with 90Y Microspheres. Liver Radioembolization with 90Y Microspheres 105 117 .
Takashi Himoto, Kazutaka Kurokohchi, Seishiro Watanabe & Tsutomu Masaki. (2012) Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepatitis Monthly 12:10 HCC.
Crossref
Cheng-Maw Ho, Po-Huang Lee, Wen-Yi Shau, Ming-Chih Ho, Yao-Ming Wu & Rey-Heng Hu. (2012) Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities. Surgery 151:5, pages 700-709.
Crossref
W.-Y. Kao, Y.-Y. Chiou, H.-H. Hung, C.-W. Su, Y.-H. Chou, J.-C. Wu, T.-I. Huo, Y.-H. Huang, W.-C. Wu, H.-C. Lin & S.-D. Lee. (2012) Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy. Clinical Radiology 67:5, pages 429-436.
Crossref
. (2012) EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 56:4, pages 908-943.
Crossref
Rinako Kawamura, Toshihito Seki, Hideto Umehara, Kozo Ikeda, Ryosuke Inokuchi, Toshiki Asayama, Takashi Yamaguchi, Yu Takahashi, Masayuki Sakao, Riccardo Lencioni & Kazuichi Okazaki. (2011) Combined Treatment of Large Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization and Percutaneous Ethanol Injection with a Multipronged Needle: Experimental and Clinical Investigation. CardioVascular and Interventional Radiology 35:2, pages 325-333.
Crossref
K. Berry & G.N. Ioannou. (2012) Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?. American Journal of Transplantation 12:3, pages 706-717.
Crossref
Charles E. RayJrJr, Catherine Battaglia, Anne M. Libby, Allan Prochazka, Stan Xu & Brian Funaki. (2012) Interventional Radiologic Treatment of Hepatocellular Carcinoma—A Cost Analysis from the Payer Perspective. Journal of Vascular and Interventional Radiology 23:3, pages 306-314.
Crossref
. (2012) EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. European Journal of Cancer 48:5, pages 599-641.
Crossref
R. Adam & M. -A. Allard. (2012) Chirurgie du carcinome hépatocellulaire: de l’exérèse à la transplantation: indications actuelles et futuresHepatocellular carcinoma surgery: from resection to transplantation: current and future indications. Oncologie 14:3, pages 164-173.
Crossref
Judith Meza-Junco, Aldo J. Montano-Loza, David M. Liu, Michael B. Sawyer, Vincent G. Bain, Mang Ma & Richard Owen. (2012) Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?. Cancer Treatment Reviews 38:1, pages 54-62.
Crossref
Hideo Fukuhara, Keiji Inoue, Takashi Karashima & Taro Shuin. (2012) Clinical experience of percutaneous radiofrequency ablation of renal cell carcinoma. Journal of Microwave Surgery 30:0, pages 247-251.
Crossref
Riccardo Lencioni & Laura Crocetti. (2012) Local-Regional Treatment of Hepatocellular Carcinoma. Radiology 262:1, pages 43-58.
Crossref
Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig & Jordi Bruix. (2012) Management of HCC. Journal of Hepatology 56, pages S75-S87.
Crossref
Sandro Rossi, Giorgia Ghittoni & Valentina Ravetta. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract 1376 1388.e3 .
Jorge A. Marrero. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 1005 1031 .
Riccardo Lencioni & Laura Crocetti. 2012. Interventional Oncology. Interventional Oncology 107 116 .
Riccardo Lencioni. 2011. Clinical Dilemmas in Primary Liver Cancer. Clinical Dilemmas in Primary Liver Cancer 142 148 .
Ah Yeong KimHyunchul RhimMinjung ParkMin Woo LeeYoung-Sun KimDongil ChoiHyo K. Lim. (2011) Venous Thrombosis After Radiofrequency Ablation for Hepatocellular Carcinoma. American Journal of Roentgenology 197:6, pages 1474-1480.
Crossref
Luis Calzadilla Bertot, Masaya Sato, Ryosuke Tateishi, Haruhiko Yoshida & Kazuhiko Koike. (2011) Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. European Radiology 21:12, pages 2584-2596.
Crossref
Hansjörg Rempp, Andreas Boss, Thomas Helmberger & Philippe Pereira. (2011) The current role of minimally invasive therapies in the management of liver tumors. Abdominal Imaging 36:6, pages 635-647.
Crossref
Maria Pipa-Muniz, Maria Varela, Luisa Gonzalez-Dieguez & Manuel Rodríguez. (2011) Personalized medicine in hepatocellular carcinoma: rationale and clinical data. Clinical Investigation 1:10, pages 1403-1411.
Crossref
L Tiong & G J Maddern. (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. British Journal of Surgery 98:9, pages 1210-1224.
Crossref
Jay Requarth. (2011) Image-Guided Palliative Care Procedures. Surgical Clinics of North America 91:2, pages 367-402.
Crossref
Tito Livraghi. (2011) Radiofrequency Ablation of Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 20:2, pages 281-299.
Crossref
Nuh N. Rahbari, Arianeb Mehrabi, Nathan M. Mollberg, Sascha A. Müller, Moritz Koch, Markus W. Büchler & Jürgen Weitz. (2011) Hepatocellular Carcinoma. Annals of Surgery 253:3, pages 453-469.
Crossref
Namiki Izumi. (2011) Recent advances of radiofrequency ablation for early hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 26:s1, pages 115-122.
Crossref
Massimo Iavarone & Massimo Colombo. (2011) HBV-related HCC, clinical issues and therapy. Digestive and Liver Disease 43, pages S32-S39.
Crossref
Riccardo Lencioni, Clotilde Della Pina, Dania Cioni & Laura Crocetti. 2011. Clinical Ultrasound. Clinical Ultrasound 167 178 .
Antonio Mussa & Sergio SandrucciC. R. Rossi, A. Comandone & A. Veltri. 2011. Nuove tecnologie chirurgiche in oncologia. Nuove tecnologie chirurgiche in oncologia 121 137 .
Tito Livraghi, Giorgio Brambilla, Carlo Carnaghi, Maurizio A. Tommasini & Guido Torzilli. (2010) Is it time to reconsider the BCLC/AASLD therapeutic flow‐chart?. Journal of Surgical Oncology 102:7, pages 868-876.
Crossref
Sheng-Long Ye, Tadatoshi Takayama, Jeff Geschwind, Jorge A. Marrero & Jean-Pierre Bronowicki. (2010) Current Approaches to the Treatment of Early Hepatocellular Carcinoma. The Oncologist 15:S4, pages 34-41.
Crossref
Riccardo Lencioni, Laura Crocetti, Dania Cioni, Clotilde Della Pina, Filippo Oliveri, Paolo De Simone, Maurizia Brunetto & Franco Filipponi. (2010) Single-session Percutaneous Ethanol Ablation of Early-stage Hepatocellular Carcinoma with a Multipronged Injection Needle: Results of a Pilot Clinical Study. Journal of Vascular and Interventional Radiology 21:10, pages 1533-1538.
Crossref
Massimo Colombo & Massimo Iavarone. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 650 660 .
Hyunchul Rhim & Hyo K. Lim. (2010) Radiofrequency Ablation of Hepatocellular Carcinoma: Pros and Cons. Gut and Liver 4:Suppl.1, pages S113.
Crossref
AKIRA MIZUKI, MASAYUKI TATEMICHI, NOBUHIRO TSUKADA, RYOUSUKE NAGAMATSU, MITSUHIKO KAWAGUCHI, TATSUYA ITOSHIMA, SHIGEKI MARUYAMA, ATSUHIKO SATOU, YASUHISA IMARI, TOSHIHARU KAWATOKO, JUNYA SHIMONO & HIROSHI NAGATA. (2010) Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study. Oncology Letters 1:5, pages 855-859.
Crossref
Riccardo Lencioni. (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:2, pages 762-773.
Crossref
Riccardo Lencioni, Laura Crocetti, Paolo De Simone & Franco Filipponi. (2010) Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects. Transplant International 23:7, pages 698-703.
Crossref
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali & Maurice A. A. J. van den Bosch. (2010) Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?. Insights into Imaging 1:3, pages 167-181.
Crossref
Riccardo Lencioni, Dania Cioni, Clotilde Della Pina & Laura Crocetti. (2009) Hepatocellular carcinoma: new options for image‐guided ablation. Journal of Hepato-Biliary-Pancreatic Sciences 17:4, pages 399-403.
Crossref
Wei Wang, Jian Shi & Wei-Fen Xie. (2010) Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver International 30:5, pages 741-749.
Crossref
Amit G Singal & Jorge A Marrero. (2010) Recent advances in the treatment of hepatocellular carcinoma. Current Opinion in Gastroenterology 26:3, pages 189-195.
Crossref
Giacomo Germani, Maria Pleguezuelo, Kurinchi Gurusamy, Tim Meyer, Graziella Isgrò & Andrew Kenneth Burroughs. (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. Journal of Hepatology 52:3, pages 380-388.
Crossref
Alejandro Forner & Jordi Bruix. (2010) Ablation for hepatocellular carcinoma: Is there need to have a winning technique?. Journal of Hepatology 52:3, pages 310-312.
Crossref
Laura Crocetti, Thierry de Baere & Riccardo Lencioni. (2009) Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours. CardioVascular and Interventional Radiology 33:1, pages 11-17.
Crossref
Hyunchul Rhim. (2010) Current status of radiofrequency ablation of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2:4, pages 128.
Crossref

Displaying 200 of 215 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.